Audioboom Group plc
ADBMF News Today: Stay Updated with the Latest Audioboom Group plc News in Real Time
Find ADBMF news now at Meyka AI. Stay informed with the latest Audioboom Group plc stocks updates, including price news, market analysis, and expert insights.
MPX.AX A$0.14 pre-market ASX oversold bounce 27 Feb 2026: Watch volume
Pre-market MPX.AX stock note: A$0.14 oversold bounce setup, valuation, Meyka AI forecast and key risks
CHF129.60 Novartis (NOVN.SW, SIX) intraday 26 Feb 2026: Meyka sees 18.35% upside
Intraday NOVN.SW stock update: Novartis at CHF129.60 on SIX, volume 3.67M, Meyka forecast shows 18.35% five-year upside
February 27: Japan AI Governance Shock After ZEN University Professor Arrest
Koichiro Eto arrest triggers JSAI suspension and apology, with ZEN University issuing a statement. We assess AI ethics Japan, governance risk, and investor watch items.
JPY 3,345 pre-market: 7386.T Japan Warranty Support JPX oversold bounce watch cash gap 27 Feb 2026
Pre-market look at 7386.T stock at JPY 3,345 showing an oversold bounce setup and cash-backed valuation
195A.T MUSCAT jumps 46.97% to JPY 1408 on 26 Feb 2026: heavy volume may extend gains
195A.T stock jumps 46.97% to JPY 1408 on 26 Feb 2026; heavy volume and strong technicals indicate follow-through risk and opportunity
0628.HK Tong Tong AI Social (HKSE) closes HK$0.19 on 26 Feb 2026: AI stock view
0628.HK stock closes HK$0.19 on 26 Feb 2026; our AI analysis, valuation and Meyka forecast included
GUI.DE stock down 14.81% intraday on 26 Feb 2026: Weak US demand drags price lower
GUI.DE stock plunges to €18.40 intraday on 26 Feb 2026 after outlook cut; Meyka AI forecast and grade included
S51.SI Stock Today: February 26 – FY Profit Doubles; S$0.03 Dividend
Seatrium share price in focus as full-year profit doubles to S$323.6m and a S$0.03 dividend is proposed. Key SGX levels, valuation, and what investors should watch next.
IDIA.SW Stock Today: FY2025 Revenue Doubles; Loss Narrows — February 26
Idorsia stock steadied near CHF 3.75 as FY2025 revenue doubled to CHF 221m and losses narrowed. Quviviq sales hit CHF 134m. 2026 guidance targets CHF 200m Quviviq and an operating loss of CHF -160m.